Comparison of the mortality and inflammatory response of two models of sepsis: Lipopolysaccharide vs. cecal ligation and puncture

Shock

Volumn 13, Issue 2, 2000, Pages 110-116

  Remick, Daniel G ^a,b   Newcomb, David E ^a   Bolgos, Gerald L ^a   Call, Douglas R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b M2210 Medical Science Bldg I ^*  (United States)

Author keywords

Chemokines; Cytokines; Interleukin 1; Interleukin 6; Lymphocytes; Neutrophils; Peritonitis; Shock; Tumor necrosis factor

Indexed keywords

CHEMOKINE; CYTOKINE; LIPOPOLYSACCHARIDE;

ANIMAL; ARTICLE; ASCITES FLUID; BAGG ALBINO MOUSE; BLOOD; CECUM; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE COUNT; LIGATION; METABOLISM; MICROBIOLOGY; MOUSE; PATHOLOGY; PUNCTURE; SEPSIS; SURVIVAL RATE; TIME;

ANIMALS; ASCITIC FLUID; CECUM; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; LEUKOCYTE COUNT; LIGATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PUNCTURES; SEPSIS; SURVIVAL RATE; TIME FACTORS;

EID: 0034132796     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200013020-00004     Document Type: Article

References (22)

1. Bone RC, Grodzin CJ, Balk RA: Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 112: 235-243, 1997.
2. Davies MG, Hagen PO: Systemic inflammatory response syndrome. British Journal of Surgery 84:920-935, 1997.
3. Woltmann A, Hamann L, Ulmer AJ, Gerdes J, Bruch HP, Rietschel ET: Molecular mechanisms of sepsis. Langenbecks Archives of Surgery 383: 2-10, 1998.
4. Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G: Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4:89-95, 1995.
5. Newcomb D, Bolgos G, Green L, Remick DG: Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity. Shock 10:110-117, 1998.
6. Remick DG, Garg SJ, Newcomb DE, Wollenberg G, Huie TK, Bolgos GL: Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis [see comments]. Critical Care Medicine 26:895-904, 1998.
7. Baker CC, Chaudry IH, Gaines HO, Baue AE: Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331-335, 1983.
8. Espevik T, Nissen Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105, 1986.
9. Eskandari MK, Nguyen DT, Kunkel SL, Remick DG: WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability. Immunological Investigations 19:69-79, 1990.
10. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM: Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411-1416, 1987.
11. DeForge LE, Remick DG: Sandwich ELISA for detection of picogram quantities of interleukin-8. Immunol Invest 20:89-97, 1991.
12. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG: Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 148:2724-2730, 1992.
13. Baue AE: Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets? [see comments]. Archives of Surgery 132:703-707, 1997.
14. Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF, et al: Antibodies to cachectin/ tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med 170:1627-1633, 1989.
15. Xing Z, Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldie J: Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation [published erratum appears in Am J Respir Cell Mol Biol 1994 Mar; 10(3): following 346]. Am J Respir Cell Mol Biol 10:148-153, 1994.
16. Cavaillon JM, Munoz C, Fitting C, Misset B, Carlet J: Circulating cytokines: the tip of the iceberg? Circ Shock 38:145-152, 1992.
17. Schein M, Wittmann DH, Holzheimer R, Condon RE: Hypothesis: compartmentalization of cytokines in intraabdominal infection. Surgery 119: 694-700, 1996.
18. Remick DG: Applied molecular biology of sepsis. J Crit Care 10:198-212, 1995.
19. Bagby GJ, Plessala KJ, Wilson LA, Thompson JJ, Nelson S: Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J Infect Dis 163:83-88, 1991.
20. Hyde SR, McCallum RE: Lipopolysaccharide-tumor necrosis factor-glucocorticoid interactions during cecal ligation and puncture-induced sepsis in mature versus senescent mice. Infect Immun 60:976-982, 1992.
21. Hadjiminas DJ, McMasters KM, Peyton JC, Cheadle WG: Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin. J Surg Res 56:549-555, 1994.
22. Villa P, Sartor G, Angelini M, Sironi M, Conni M, Gnocchi P, Isetta AM, Grau G, Buurman W, van Tits LJ: Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clinical & Diagnostic Laboratory Immunology 2:549-553, 1995.